Compare CRK & BCPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CRK | BCPC |
|---|---|---|
| Founded | 1983 | 1967 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Major Chemicals |
| Sector | Energy | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.9B | 5.8B |
| IPO Year | 1995 | 1995 |
| Metric | CRK | BCPC |
|---|---|---|
| Price | $21.03 | $170.63 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 10 | 2 |
| Target Price | $22.30 | ★ $176.00 |
| AVG Volume (30 Days) | ★ 2.0M | 151.9K |
| Earning Date | 04-29-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 0.56% |
| EPS Growth | ★ 288.16 | 20.87 |
| EPS | 1.43 | ★ 4.75 |
| Revenue | $555,231,000.00 | ★ $799,023,000.00 |
| Revenue This Year | N/A | $8.47 |
| Revenue Next Year | $17.48 | $4.89 |
| P/E Ratio | ★ $15.32 | $35.89 |
| Revenue Growth | ★ 32.11 | 13.56 |
| 52 Week Low | $14.65 | $139.17 |
| 52 Week High | $31.17 | $183.90 |
| Indicator | CRK | BCPC |
|---|---|---|
| Relative Strength Index (RSI) | 49.57 | 52.16 |
| Support Level | $20.35 | $165.89 |
| Resistance Level | $22.07 | $171.50 |
| Average True Range (ATR) | 1.25 | 4.23 |
| MACD | 0.13 | 0.30 |
| Stochastic Oscillator | 38.26 | 81.34 |
Comstock Resources Inc is an independent natural gas producer operating in the Haynesville shale, a natural gas basin located in North Louisiana and East Texas with superior economics given its geographical proximity to the Gulf Coast natural gas markets. The Company operates in one business segment, the exploration and production of North American natural gas and oil. It is engaged in the acquisition, development, production, and exploration of oil and natural gas. The company's oil and gas operations are concentrated in Louisiana and Texas.
Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries.